Franklin Resources
FULC icon

Franklin Resources’s Fulcrum Therapeutics FULC Stock Holding History

Franklin Resources’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$419K Buy
54,666
+10,417
+24% +$96.6K ﹤0.01% 2534
2025
Q4 		$500K Sell
44,249
-15,773
-26% -$161K ﹤0.01% 2404
2025
Q3 		$552K Hold
60,022
– – ﹤0.01% 2389
2025
Q2 		$413K Buy
60,022
+35,201
+142% +$188K ﹤0.01% 2411
2025
Q1 		$71.5K Hold
24,821
– – ﹤0.01% 2836
2024
Q4 		$117K Hold
24,821
– – ﹤0.01% 2742
2024
Q3 		$88.6K Hold
24,821
– – ﹤0.01% 2756
2024
Q2 		$154K Hold
24,821
– – ﹤0.01% 2614
2024
Q1 		$234K Hold
24,821
– – ﹤0.01% 2541
2023
Q4 		$168K Sell
24,821
-3,535
-12% -$15.7K ﹤0.01% 2386
2023
Q3 		$126K Hold
28,356
– – ﹤0.01% 2425
2023
Q2 		$93.6K Buy
+28,356
New +$83.3K ﹤0.01% 2546

Other funds holding FULC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
FTM
First Turn Management Del Mar, California $895M AUM 261.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Franklin Resources's FULC Position: Q1 2026 in Review

Franklin Resources increased its Fulcrum Therapeutics (FULC) stake by 24% in Q1 2026, buying an estimated $96.6K and bringing the position to 54,666 shares worth $419K. The position accounts for ﹤0.01% of the portfolio, ranked #2534.

Franklin Resources first reported a position in FULC in Q2 2023 and has held it in 12 quarters since. The position peaked at $552K in Q3 2025. 169 funds tracked by Wall St. Rank hold FULC as of Q1 2026.

  • Franklin Resources held 54,666 shares of Fulcrum Therapeutics worth $419K as of Q1 2026.
  • Franklin Resources bought 10,417 Fulcrum Therapeutics shares in Q1 2026, an estimated $96.6K.
  • Fulcrum Therapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q1 2026, its #2534 holding.
  • Franklin Resources first reported a position in Fulcrum Therapeutics in Q2 2023 and has held it in 12 quarters since.
  • Franklin Resources's Fulcrum Therapeutics position peaked at $552K in Q3 2025.
  • 169 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.